Search the webpage

Category: Angiogenesis

To test the anti-angiogenic potential of an NCE/compound in human umbilical vein endothelial cells (HUVEC) in vitro.

SUMMARY

Cells

Human umbilical vein endothelial cells (HUVEC)

Format

15-well µ-Slide Angiogenesis (Ibidi GmbH, Germany)

Angiogenic inducers and positive control

Inducers: incl. angiogenin and VEGF;
Positive control: sulforaphane.

Analysis

ImageJ or Wimasis (Khoo et al., 2011)

Please contact us, if you would like to receive more information: info@experimentica.com

IMAGES

Human umbilical vein endothelial cells (HUVECs)

Assessment of anti-angiogenic properties of sulforaphane after an induction of angiogenesis using angiogenic and VEGF

SELECTED PUBLICATIONS

  • Park HJ, Zhang Y, Georgescu SP, Johnson KL, Kong D, Galper JB. Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis. Stem Cell Rev. 2006;2(2):93-102. Review. PubMed PMID: 17237547.
  • Cao Y, Gong Y, Liu L, Zhou Y, Fang X, Zhang C, Li Y, Li J. The use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: a review. J Appl Toxicol. 2017 Dec;37(12):1359-1369. doi: 10.1002/jat.3470. Epub 2017 Apr 6. Review. PubMed PMID: 28383141.

REFERENCES

  • Khoo CP, Micklem K, Watt SM. A comparison of methods for quantifying angiogenesis in the Matrigel assay in vitro. Tissue Eng Part C Methods. 2011 Sep;17(9):895-906. doi: 10.1089/ten.TEC.2011.0150. Epub 2011 Jun 8. PubMed PMID: 21517696;

Leave a Comment

LATEST NEWS

Experimentica Ltd. Sponsors the 2018 SILK-Elsemay Björn Symposium

News
Experimentica Ltd. is pleased to announce its co-sponsorship and participation in this year’s SILK - Elsemay Björn Symposium. This yearly ... Read More

Check out our new publication on the mouse dry-eye disease model

An alpha1 adrenergic agonist shows preclinical efficacy in a preclinical model for dry eye syndrome ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!